Universe Pharmaceuticals Stock Market Value
| UPC Stock | USD 1.86 0.07 3.63% |
| Symbol | Universe |
Universe Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (76.35) | Revenue Per Share 7.351 | Quarterly Revenue Growth (0.30) | Return On Assets (0.06) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Universe Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Universe Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Universe Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Universe Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Universe Pharmaceuticals or generate 0.0% return on investment in Universe Pharmaceuticals over 30 days. Universe Pharmaceuticals is related to or competes with Regencell Bioscience, Im Cannabis, Raphael Pharmaceutical, Procaps Group, Phibro Animal, and Alpha Teknova. Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of... More
Universe Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Universe Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Universe Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.30) | |||
| Maximum Drawdown | 73.25 | |||
| Value At Risk | (16.26) | |||
| Potential Upside | 12.27 |
Universe Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Universe Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Universe Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Universe Pharmaceuticals historical prices to predict the future Universe Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.21) | |||
| Jensen Alpha | (3.71) | |||
| Total Risk Alpha | (5.70) | |||
| Treynor Ratio | (143.01) |
Universe Pharmaceuticals Backtested Returns
Universe Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.3, which indicates the firm had a -0.3% return per unit of risk over the last 3 months. Universe Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Universe Pharmaceuticals' Risk Adjusted Performance of (0.21), variance of 161.34, and Coefficient Of Variation of (343.86) to confirm the risk estimate we provide. The entity has a beta of 0.0259, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Universe Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Universe Pharmaceuticals is expected to be smaller as well. At this point, Universe Pharmaceuticals has a negative expected return of -3.84%. Please make sure to validate Universe Pharmaceuticals' value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Universe Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.82 |
Very good predictability
Universe Pharmaceuticals has very good predictability. Overlapping area represents the amount of predictability between Universe Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Universe Pharmaceuticals price movement. The serial correlation of 0.82 indicates that around 82.0% of current Universe Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.82 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.42 |
Universe Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Universe Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Universe Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Universe Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Universe Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Universe Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Universe Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Universe Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Universe Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Universe Pharmaceuticals Lagged Returns
When evaluating Universe Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Universe Pharmaceuticals stock have on its future price. Universe Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Universe Pharmaceuticals autocorrelation shows the relationship between Universe Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Universe Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:Check out Universe Pharmaceuticals Correlation, Universe Pharmaceuticals Volatility and Universe Pharmaceuticals Alpha and Beta module to complement your research on Universe Pharmaceuticals. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Universe Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.